Cantitate/Preț
Produs
Total produse
Vezi coșul
The Politics of the Pharmaceutical Industry and Access to Medicines: World Pharmacy and India de Hans Löfgren

The Politics of the Pharmaceutical Industry and Access to Medicines: World Pharmacy and India

Editat de Hans Löfgren
en Limba Engleză Paperback – 25 iun 2024
The book studies the pharmaceutical industry of India. It is one of the most successful stories of economic expansion and improvements in public health. Indian firms have made access to quality medicines possible and affordable in many developing countries. Indian pharmaceuticals are also exported on a large scale to the United States and other highly regulated markets. A wave of mergers, acquisitions and tie-ups point to growing integration between Indian firms and global pharma multinationals.


Please note: Taylor & Francis does not sell or distribute the Hardback in India, Pakistan, Nepal, Bhutan, Bangladesh and Sri Lanka
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 25404 lei  6-8 săpt.
  Taylor & Francis – 25 iun 2024 25404 lei  6-8 săpt.
Hardback (1) 99290 lei  6-8 săpt.
  Taylor & Francis – 21 iun 2017 99290 lei  6-8 săpt.

Preț: 25404 lei

Preț vechi: 32340 lei
-21% Nou

Puncte Express: 381
Preț estimativ în valută:
4865€ • 5013$ • 4076£

Carte tipărită la comandă

Livrare economică 24 februarie-10 martie

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781032652924
ISBN-10: 1032652926
Pagini: 370
Dimensiuni: 138 x 216 mm
Greutate: 0.16 kg
Ediția:1
Editura: Taylor & Francis
Colecția Routledge
Locul publicării:Oxford, United Kingdom

Public țintă

Postgraduate

Notă biografică

Hans Löfgren is Associate Professor in Politics and Policy Studies, Deakin University, Melbourne, Australia.

Cuprins

  1. The Pharmaceutical Industry and Access to Medicines in India
    The Pre-1972 Product Patent Period
    The Process Patent Era 1972–2005
    Full TRIPS-compliance from 2005
    Financial and Economic Crisis and Access to
    Medicines for All
  2. Challenges of Regulation of Medicines in India Price Regulation
    Weeding Out of Irrational Medicines: A Necessary
    Complement to Price Control
    Law on Banning Irrational Medicines
    Towards Ethical Marketing and Promotion of Medicines
    Promoting Transparency and Declarations of Conflict
    of Interest
    General Review of all Legislations
    Other Issues
    Conclusion
  3. CIPLA: Patients before Patents Modest Beginnings
    Yusuf Hamied Living up to his Legacy
    India’s Patent Law 1972
    The Three Drug Combination: Potent Cocktail
    A Life-saving Offer
    Success Story
    The Road Ahead
  4. Systemic Failure of Regulation: The Political Economy of Pharmaceutical and Bulk Drug Manufacturing
    The Regulation of Industrial Pollution
    Structure and Methodology
    Structures of the Value Chains in the Rural Economy
    Pathways of Pollution in the Dairy Industry
    Regulatory Checks on Pathways in Value Chains
    Final Observations
  5. TRIPS Flexibilities and Access to Patented Medicines in India
    Use of Trips Flexibilities
    Exemptions from Patentability
    Future Options
  6. India’s Free Trade Agreements: Implications for Access to Medicines in India and the Global South
    Introduction
    TRIPS Compliance: Using the Doha Declaration
    in India
    India’s FTA Negotiations: An Overview
    FTAs and Access to Medicines: Key Concerns
    Intellectual Property Provisions
    Investment (or Investor Protection) Measures
    Regulatory Harmonization

    Government of India’s Position
    FTAs, TRIPS and the Right to Health
    Conclusion
  7. At any Price? Boehringer Ingelheim, Bayer HealthCare and Baxter in India
    The Examined Companies
    How Good are the Drugs Supplied by these Companies?
    What about Access?
    Drug Treatment in the NGO, Private and Public Sectors
    Research and Patents
    Marketing and Business Behaviour
    Conclusion
  8. Trends and Prospects for India as a Global Generic Player
    Introduction
    Regulatory Status of India in World Generics
    Markets
    India’s Bilateral Trade in Pharmaceutical Products
    Outlook for the Indian Pharmaceutical Industry
    TRIPS and the Future of the Indian Pharmaceutical
    Industry
    Conclusion
  9. The Indian Patent Law and Access to Antiretroviral Drugs in Sub-Saharan Africa
    TRIPS and Public Health
    Compulsory Licensing
    Parallel Imports
    The Scope of Patentability
    Indian Patent Law
    African Patent Laws
    The Impact of the Patent Status in India on Access
    in Sub-Saharan Africa
    Lacking Access to Patented Radical Innovative
    Antiretrovirals
    Patents Matter
  10. Accessing Medicines in Developing Economies Intersection between IPRs and Competition Law
    Refusal to Licence Pharmaceutical Patents in
    South Africa
    Some Considerations
    Abbott’s Withdrawal of Medicine Registration
    Applications in Thailand
    Exclusive Distribution and the High Prices of
    Medicines in Vietnam
    Indian Perspective
    Concluding Remarks
  11. The Politics of AIDS Treatment in Brazil Introduction
    The Strategy of Local Generic Production
    Challenges to the Sustainability of an Inclusive AIDS
    Treatment Policy
    Restricting Patent Rights to Reduce ARV Costs
    Conclusions
  12. Financing Pharmaceutical Research and Development: Alternatives to the Patent System
    Problems with the Patent System
    Alternative Mechanisms for Financing R&D
    Conclusion
  13. Post-script
Glossary

Descriere

The book studies the pharmaceutical industry of India. It is one of the most successful stories of economic expansion and improvements in public health. Indian firms have made access to quality medicines possible and affordable in many developing countries. Indian pharmaceuticals are also exported on a large scale to the United States and other